Denial in cancer patients

Cancer Investigation

Volumn 17, Issue 7, 1999, Pages 514-534

  Kreitler, Shulamith ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PATIENT; CANCER PREVENTION; CANCER SURVIVAL; COPING BEHAVIOR; DENIAL; HUMAN; IMMUNE SYSTEM; PATIENT ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0032867671     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032861     Document Type: Review

References (178)

1. Dorpat TL: Denial and Defense in the Therapeutic Situation, Northvale NJ, Jason Aronson, 1994.
2. Eidelberg L (Ed): Encyclopedia of Psychoanalysis. New York, Free Press, 1968.
3. Freud A: The Ego and the Mechanisms of Defense. New York, International Universities Press, 1936.
4. Freud S: Repression. In: The Standard Edition of the Complete Psychological Works of Sigmund Freud, edited by J Strachey, vol. 14, London, Hogarth Press, 1915, pp. 146-158.
5. Freud S: Inhibitions, symptoms and anxiety. In: The Standard Edition of the Complete Psychological Works of Sigmund Freud, edited by J Strachey, vol. 20, London, Hogarth Press, 1926, pp. 77-174.
6. Higgins JE, Endler NS: Coping, life stress, and psychological and somatic distress. Eur J Personality 9:253-270, 1995.
7. Holahan CJ, Moos RH: Risk, resistance and psychological distress: a longitudinal analysis with adults and children. J Abnorm Psych 96:3-13, 1987.
8. Vaillant GE: Adapting to Life. Boston, Little, Brown and Company, 1977.
9. Billings AG, Moos RH: The role of coping responses and social resources in attenuating the stress of life events. J Behav Med 4:139-157, 1981.
10. Suls J, Fletcher B: The relative efficacy of avoidant and non-avoidant coping strategies: a meta-analysis. Health Psychol 4: 249-288, 1985.
11. Ness DE, Ende J: Denial in the medical interview: recognition and management. JAMA 272:1777-1781, 1994.
12. Froese A, Hackett TP, Cassem NH: Trajectories of anxiety and depression in denying and nondenying acute myocardial infarction patients during hospitalization. J Psychosom Res 18: 413-420, 1974.
13. Breznitz S: The seven kinds of denial. In: The Denial of Stress, edited by S. Breznitz, New York, International Universities Press, 1983.
14. Weisman AD: On Dying and Denying: A Psychiatric Study of Terminality. New York, Behavioral Publications, 1972.
15. Weinstein EA, Kahn RL: Denial of Illness. Springfield, IL, Charles C Thomas, 1955.
16. Greer S: The management of denial in cancer patients. Oncol-Huntington 6:33-36, 39-40, 1992.
17. Wool MS, Goldberg RJ: Assessment of denial in cancer patients: implications for intervention. J Psychosoc Oncol 4:1-14, 1986.
18. Levy SM: Behavior and Cancer, San Francisco, CA, Jossey-Bass, 1985.
19. Lee C: Perceptions of immunity to disease in adult smokers. J Behav Med 12:267-277, 1989.
20. Sandfort TG, Van Zessen G: Denial as a barrier for HIV prevention within the general population. J Psychol Human Sexual 5: 69-87, 1992.
21. Gabrielli F, Camisassi A, Caffarena O, et al: Psychological management in cancer prevention: an experience with a group of medical students. Riv Speriment Freniatr Med Leg Alien 108: 37-45, 1984.
22. Antonovsky A, Hartman H: Delay in the detection of cancer: a review of the literature. Health Educ Monogr 2:98-128, 1974.
23. Magarey CJ, Todd PB, Blizard PJ: Psycho-social factors influencing delay and breast self-examination in women. Soc Sci Med 11:229-232, 1977.
24. Hackett TP, Cassem NH, Raker JW: Patient delay in cancer. N Engl J Med 289:14-20, 1973.
25. Chamberlain RM, Lane M, Weinberger AD, et al: Application of cancer prevention knowledge: a longitudinal follow-up study of medical students. J Cancer Educ 2:93-106, 1987.
26. Buttlar CA, Tempelton AC: The size of breast masses at presentation: the impact of prior medical training. Cancer 51:1750-1753, 1983.
27. Wilkes E, Schoenfeld ER, Ruesch DC, et al: The planning, execution and evaluation of a breast cancer detection awareness program. J Cancer Educ 3:247-255, 1988.
28. Herman SH, Wandersman A: Measuring knowledge of cancer. Soc Sci Med 32:1245-1255, 1991.
29. Henderson JG: Denial and repression as factors in the delay of patients with cancer presenting themselves to the physician. Ann NY Acad Sci 125:856-864, 1966.
30. Zervas IM, Augustine A, Fricchione GL: Patient delay in cancer: a view from the crisis model. Gen Hosp Psychiatr 15:9-13, 1993.
31. Greer S: Psychological aspects: delay in the treatment of breast cancer. Proc R Soc Med 67:470-473, 1974.
32. Wool MS: Extreme denial in breast cancer patients and capacity for object relations. Psychother Psychosom 46:196-204, 1986.
33. Phelan M, Dobbs J, David AS: "I thought it would go away": patient denial in breast cancer. J Res Soc Med 85:206-207, 1992.
34. Kelly PT: Breast self-examinations: who does them and why. J Behav Med 2:31-38, 1979.
35. Davey GC, Tallis F, Hodgson S: The relationship between information-seeking and information-avoiding coping styles and the reporting of psychological and physical symptoms. J Psychosom Res 37:333-344, 1993.
36. Goldsen RK, Gerhardt PR, Handy VH: Some factors related to patient delay in seeking diagnosis for cancer symptoms. Cancer 10:1-7, 1957.
37. Chaitchik S, Kreitler S: Induced versus spontaneous attendance of breast-screening tests by women. J Cancer Educ 6:43-53, 1991.
38. Temoshok L, Diclemente RJ, Sweet DM, et al: Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 54:3048-3053, 1984.
39. Kreitler S, Chaitchik S, Kreitler H: The psychological profile of women attending breast-screening tests. Soc Sci Med 31:1177-1185, 1990.
40. Kreitler S, Chaitchik S, Kreitler H, et al: Who will attend tests for the early detection of breast cancer? Psychol Health 9:463-483, 1994.
41. Keinan G, Carmil D, Rieck M: Predicting women's delay in seeking medical care after discovery of a lump in the breast: the role of personality and behavior patterns. Behav Med 17:177-189, 1991.
42. Watson M, Greer S, Blake S, et al: Reaction to a diagnosis of breast cancer: relationship between denial, delay and rates of psychological morbidity. Cancer 53:2008-2012, 1984.
43. Kreitler S, Chaitchik S, Kreitler H: Repressiveness: cause or result of cancer? Psycho-Oncol 2:43-54, 1993.
44. Morris T, Greer S, White P: Psychological and social adjustment to mastectomy: a two-year follow-up study. Cancer 40:2381-2387, 1977.
45. Filipp S-H: Could it be worse? The diagnosis of cancer as a prototype of traumatic life events. In: Life Crises and Experiences of Loss in Adulthood, edited by L. Montada, S-H Filipp, MJ Lerner, Hillsdale NJ, Erlbaum, 1992, pp. 23-56.
46. Palmer AG, Tucker S, Warren R, et al: Understanding women's responses to treatment for cervical intraepithelial neoplasm. Br J Clin Psychol 32:101-112, 1993.
47. Wirsching M, Stierlin H, Hoffman F, et al: Psychological identification of breast cancer patients before biopsy. J Psychosom Res 26:1-11, 1982.
48. Stanton AL, Snider PR: Coping with a breast cancer diagnosis: a prospective study. Health Psychol 12:16-23, 1993.
49. Carver CS, Pozo C, Harris SD, et al: How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. J Personality Soc Psychol 65:375-390, 1993.
50. Jelicic M, Bonke B, Millar K: Clinical note on the use of denial in patients undergoing surgery for breast cancer. Psychol Rep 72:952-954, 1993.
51. Burgess C, Morris T, Pettingale KW: Psychological response to cancer diagnosis. II. Evidence for coping styles (coping styles and cancer diagnosis). J Psychosom Res 32:263-272, 1988.
52. Grassi L, Rosti G, Albieri G, et al: Correlati psicipatologici della repressione emozionale in pazienti neoplastici (Psychopathological correlates of affective repression in cancer patients). Riv Psichiatr 22:297-303, 1987.
53. Ward SE, Leventhal H, Love R: Repression revisited: tactics used in coping with a severe health threat. Personality Soc Psychol Bull 14:735-746, 1988.
54. Filipp S-H, Klauer T: Subjective well-being in the face of critical life events: the case of successful copers. In: Subjective Well-Being: An Interdisciplinary Perspective, edited by F Strack, M Argyle, N Schwartz, Oxford, Pergamon, 1991, pp. 213-234.
55. Baider L, De-Nour AK: Group therapy with adolescent cancer patients. J Adolesc Health Care 10:35-38, 1989.
56. Kreitler S, Shaked S, Chaitchik S, et al: Medical characteristics, control and anxiety as determinants of adjustment to cancer. In: Personality Psychology in Europe, vol. 6, edited by J Bermúdez, B de Raad, J de Vries, et al., The Netherlands, Swets and Zeitlinger, 1997.
57. Kreitler S, Kreitler H, Chaitchik S, et al: Cognitive orientation and survival in cancer patients. Paper presented at the 10th European Health Psychology Society Conference, Dublin, Ireland, September 1996.
58. Kreitler S, Kreitler H, Chaitchik S, et al: Psychological and medical predictors of disease course in breast cancer: a prospective study. Eur J Personality 11:383-400, 1997.
59. Goldberg RJ: Systematic understanding of cancer patients who refuse treatment. Psychother Psychosom 39:180-189, 1983.
60. Friedman LC, Baer PE, Lewy A, et al: Predictors of psychosocial adjustment to breast cancer. J Psychosoc Oncol 6:75-94, 1988.
61. Ross DM, Peteet JR, Medeiros C, et al: Difference between nurses' and physicians' approach to denial in oncology. Cancer Nurs 15:422-428, 1992.
62. Tamaroff MH, Festa RS, Adesman AR, et al: Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 120:812-817, 1992.
63. Orr E: Open communication as a effective stress management method for breast cancer patients. J Hum Stress 12:175-185, 1986.
64. Meyerowitz BE: Postmastectomy coping strategies and quality of life. Health Psychol 2:117-132, 1983.
65. Gibertini M, Reintgen DS, Balie WF: Psychosocial aspects of melanoma. Ann Plastic Surg 28:17-21, 1992.
66. Canning EH, Canning RD, Boyce WT: Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatr 31:1120-1124, 1992.
67. Koller M, Kussman J, Lorenz W, et al: Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer 77:983-995, 1996.
68. Dougherty K, Templer DT, Brown R: Psychological states in terminal cancer patients as measured over time. J Counsel Psychol 33:357-359, 1986.
69. Hinton J: Which patients with terminal cancer are admitted from home care? Palliat Med 8:197-210, 1994.
70. Kreitler S, Chaitchik S, Rapoport Y, et al: Psychosocial effects of level of information and severity of disease on head-and-neck cancer patients. J Cancer Educ 10:144-154, 1995.
71. Bacon CL, Rennecker R, Cutler M: A psychosomatic survey of cancer of the breast. Psychosom Med 14:453-460, 1952.
72. Blumberg AM, West PM, Ellis FW: A possible relationship between psychological factors and human cancer. Psychosom Med 16:27-86, 1954.
73. Trunnel JB: Second Report on Institutional Research Grants of the American Cancer Society. American Cancer Society, New York, 1952.
74. Temoshok L, Heller BW: On comparing apples, oranges and fruit salad: a methodological overview of medical outcome studies in psychosocial oncology. In: Psychosocial Stress and Cancer, edited by CL Cooper, Wiley, London, 1984, pp. 231-260.
75. Allen LR, Zigler E: Psychological adjustment of seriously ill children. J Am Acad Child Psychiatr 25:708-712, 1986.
76. Angelopoulos NV, Tzivaridou D, Nikolaou N, et al: Mental symptoms, hostility features and stressful life events in people with cancer. Acta Psych Scand 92:44-50, 1995.
77. Bahnson CB, Bahnson MB: Role of the ego defenses: denial and repression in the aetiology of malignant neoplasm. Ann NY Acad Sci 125:846-855, 1966.
78. Bahnson CB: Psychophysiological complementarity in malignancies. Ann NY Acad Sci 164:319-339, 1969.
79. Bond MR: The relation of pain to the Eysenck Personality Inventory, Cornell Medical Index and Whitley Index of Hypochondriasis. Br J Psychiatr 119:671-678, 1971.
80. Cooper CL, Faragher EB: Psychosocial stress and breast cancer: the inter-relationship between stress events, coping strategies and personality. Psychol Med 23:653-662, 1993.
81. Goldstein DA, Antoni MH: The distribution of repressive coping styles among non-metastatic and metastatic breast cancer patients as compared to non-cancer patients. Psychol Health 3: 245-258, 1989.
82. Grassi L, Capellari L: State and trait psychological characteristics of breast cancer patients. New Trends Exp Clin Psychiatr 4: 99-109, 1988.
83. Greer S., Morris T: Psychological attributes of women who develop breast cancer: a controlled study. J Psychosom Res 19: 147-153, 1975.
84. Huggan RE: Neuroticism, distortion and objective manifestations of anxiety in males with malignant disease. Br J Soc Clin Psychol 7:280-285, 1968.
85. Jansen MA, Muenz LR: A retrospective study of personality variables associated with fibrocystic disease and breast cancer. J Psychosom Res 28:35-45, 1984.
86. Kendig IV: The denial of illness. Br J Medic Psychol 36:37-47, 1963.
87. Kneier AW, Temoshok L: Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular patients. J Psychosom Res 28:145-155, 1984.
88. Kune GA, Kune S, Watson LF, et al: Personality as a risk factor in large bowel cancer: data from the Melbourne Colorectal Cancer Study. Psychol Med 21:29-41, 1991.
89. LeShan L: Psychological states as factors in the development of malignant disease: a critical review. J Natl Cancer Inst 22:1-18, 1959.
90. LeShan L, Worthington RE: Some psychologic correlates of neoplastic disease: a preliminary report. J Clin Exp Psychopathol 16:281-295, 1955.
91. Levine J, Zigler E: Denial and self-image in stroke, lung cancer, and heart disease patients. J Consult Clin Psychol 43:751-757, 1975.
92. Mucelli R: Anxiety, depression and defense mechanisms in patients hospitalized from pulmonary carcinoma. Riv Psichiatr 17: 194-206, 1982.
93. Plumb M, Holland J: Comparative studies of psychological function in patients with advanced cancer. II. Interviewer-rated current and past psychological symptoms. Psychosom Med 43:243-254, 1981.
94. Ratcliffe MA, Dawson AA, Walker LG: Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psycho-Oncol 4:39-45, 1995.
95. Sammallhati P, Lehto-Salo P, Maenpaa H, et al: Psychological defenses of young osteosarcoma survivors. Psycho-Oncol 4: 283-286, 1995.
96. Schreg H, Cramer I, Blohmke M: Psychosocial factors and breast cancer: a critical reevaluation of established hypotheses. Cancer Detect Prevent 4:165-171, 1981.
97. Swan GE, Carmelli D, Dame A, et al: The Rationality/Emotional Defensiveness Scale. II. Convergent and discriminant correlational analysis in males and females with and without cancer. J Psychosom Res 36:349-359, 1992.
98. Tarlau M, Smalheiser I: Personality patterns of patients with malignant tumors of the breast and cervix. Psychosom Med 13: 117-121, 1951.
99. Todd PB, Magarey CJ: Ego defenses and affects in women with breast symptoms: a preliminary measurement paradigm. Br J Medic Psychol 51:177-189, 1978.
100. Van-der-Ploeg HM, Kleijn WC, Mook J, et al: Rationality and anti-emotionality as a risk factor for cancer: concept differentiation. J Psychosom Res 33:217-225, 1989.
101. Yamagiwa M, Harada T, Kubo M, et al: Psychological states and personality as factors in the morbidity of head and neck malignant tumors. Nippon Jibiinkoka Bakkai Kaiho 94:67-73, 1991.
102. Anagnostopoulos F, Vaslamatzis G, Markidis M, et al: An investigation of hostile and alexithymic characteristics in breast cancer patients. Psychother Psychosom 59:179-189, 1993.
103. Bilek P, Frischenschlager O, Reiner G, et al: Einschaetzung der Malignitaet/Benignitaet einer neoplastischen Veraenderung der Brust mit Hilfe von psychosozialen Parametern bei Patientinnen einer Brustambulanz. (Assessment of malignancy/benignity of a neoplastic change in the breast by means of psychosocial parameters in patients of an ambulatory breast clinic). Psychother Med Psychol 38:420-424, 1988.
104. Cooper CL, Davies-Cooper RF, Faragher EB: A prospective study of the relationship between breast cancer and life events, type A behavior, social support and coping skills. Stress Med 2: 271-278, 1986.
105. Edwards JR, Cooper CL, Pearl SG, et al: The relationship between psychosocial factors and breast cancer: some unexpected results. Behav Med 16:5-14, 1990.
106. Katz J, Gallagher T, Hellma L, et al: Psychoendocrine considerations in cancer of the breast. Ann NY Acad Sci 164:509-534, 1969.
107. Kissen DM: The significance of personality in lung cancer in men. Ann NY Acad Sci 125:820-826, 1966.
108. Kissen DM, Brown RIF, Kissen MA: A further report on personality and psychosocial factors in lung cancer. Ann NY Acad Sci 164:535-545, 1969.
109. Morris T, Greer S, Pettingale KW, et al: Patterns of expression of anger and their psychological correlates in women with breast cancer. J Psychosom Res 25:111-117, 1981.
110. Quander-Blaznik, J: Personality as a predictor of lung cancer: a replication. Personality Indiv Diff 12:125-130, 1991.
111. Schonfield J: Psychological and life-experience differences between Israeli women with benign and cancerous breast lesions. J Psychosom Res 19:229-234, 1975.
112. Voth HM: Cancer and personality. Percept Motor Skills 42: 1131-1137, 1976.
113. Glaus, A: Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1:305-315, 1993.
114. Schwarz R: Psychosoziale Faktoren in der Karzinogenese: Zur Problematik der sogennanten Krebspersoenlichkeit (Psychosocial factors in carcinogenesis: the problem of the so-called cancer personality). Psychother Psychosom Med Psychol 43:1-9, 1993.
115. Bieliauskas LA, Garron DC: Psychological depression and cancer. Gen Hosp Psychiatr 4:187-195, 1982.
116. Bleiker EM, Van-der-Ploeg HM, Hendriks JH, et al: Rationality, emotional expression and control: psychometric characteristics of a questionnaire for research in psycho-oncology. J Psychosom Res 37:861-872, 1993.
117. Dattore PJ, Shontz FC, Coyne L: Premorbid personality differentiation of cancer and noncancer groups: a test of the hypothesis of cancer proneness. J Consult Clin Psychol 48:388-394, 1980.
118. Graves PL, Mead LA, Thomas AP: The Rorschach Interaction Scale as a potential predictor of cancer. Psychosom Med 48: 549-563, 1986.
119. Grossarth-Maticek R: Psychosocial predictors of cancer and internal diseases: an overview. Psychother Psychosom 33:122-128, 1980.
120. Grossarth-Maticek R, Kanazir DT, Hermann V, et al: Psychosomatic factors involved in the process of carcinogenesis. Psychother Psychosom 40:191-210, 1983.
121. Grossarth-Maticek R, Kanazir DT, Schmidt P, et al: Psychosocial and organic variables as predictors of lung cancer, cardiac infarct and apoplexy: some differential predictors. Personality Indiv Diff 6:313-321, 1985.
122. Hagnell B: The premorbid personality of persons who developed cancer in a total population investigated in 1947 and 1957. Ann NY Acad Sci 125:846-855, 1966.
123. Persky VW, Kempthorne-Rawson J, Shekelle RB: Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 49:435-449, 1987.
124. Thomas CB, Duszynski KR: Closeness to parents and family constellation in a prospective study of five disease states: suicide, mental illness, malignant tumor and coronary heart disease. Johns Hopkins Med J 134:251-270, 1974.
125. Fox BH: Psychosocial factors in cancer incidence and prognosis. In: Psychooncology, edited by J Holland, New York, Oxford University Press 1998, pp. 110-124.
126. Greer S, Morris T, Pettingale KW: Psychological response to breast cancer: effect on outcome. Lancet 2:785-787, 1979.
127. Greer S, Morris T, Pettingale KW, Haybittle JL: Psychological response to breast cancer and 15-year outcome. Lancet 1:49-50, 1990.
128. Pettingale KW, Morris T, Greer S: Mental attitudes to cancer: an additional prognostic factor. Lancet i:750, 1985.
129. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Does psychological response influence survival from breast cancer? Psycho-Oncology 7:284, 1998 (abstract).
130. Dean C, Surtees PG. Do psychological factors predict survival in breast cancer? J Psychosom Res 33:561-569, 1989.
131. Epping-Jordan JE, Compas BE, Howell DC: Predictors of cancer progression in young adult men and women: avoidance, intrusion thoughts, and psychological symptoms. Health Psychol 13: 539-547, 1994.
132. Leigh H, Ungerer J, Percarpio B: Denial and helplessness in cancer patients undergoing radiation therapy: sex differences and implications for prognosis. Cancer 45:3086-3089, 1980.
133. Achte K, Vauhkonen ML, Achte A-M: Psychological factors and prognosis in cancer. Psychiatr Fenn 19-24, 1979.
134. Achtenberg J, Lawlis GF: Psychological factors and blood chemistry as disease outcome predictors for cancer patients. Mutivar Exp Clin Res 3:107-122, 1977.
135. Blumberg EM, West PM, Ellis FW: A possible relationship between psychological factors and human cancer. Psychosom Med 16:277-286, 1954.
136. Brandberg Y, Mansson BE, Ringborg U, et al.: Psychological reactions in patients with malignant melanoma. Eur J Cancer 31A:157-162, 1995.
137. Buddeberg C, Wolf M, Sieber A, et al: Coping strategies and course of disease of breast cancer patients. Psychother Psychosom 55:151-157, 1991.
138. Cassileth BR, Lusk EJ, Miller DS, et al: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 312: 1551-1555, 1985.
139. Hislop TJ, Waxler NE, Coldman AJ, et al: The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis 40:729-735, 1987.
140. Jensen MR: Psychobiological factors predicting the course of breast cancer. J Personality 55:317-342, 1987.
141. Jamison RN, Burish TG, Wallston KA: Psychogenic factors in predicting survival of breast cancer patients. J Clin Oncol 5:768-772, 1987.
142. Krasnoff A: Psychosocial variables and human cancer: a cross-validation study. Psychosom Med 21:291-295, 1959.
143. Richardson JL, Zarneghar Z, Bisno B, et al: Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res 34:189-201, 1990.
144. Schwartz, GE: Psychobiology of repression and health: a systems approach. In: Repression and Dissorciation, edited by JL Singer, Chicago IL, Chicago University Press, 1990.
145. Temoshok L, Fox BH: Coping styles and other psychosocial factors related to medical status and to prognosis in patients with cutaneous malignat melanoma. In: Impact of Psychoendocrine Systems on Cancer and Immunity, edited by BH Fox, BH Newberry, Lewiston NY, C.J. Hogrefe, 1984, pp. 258-287.
146. Thomas C, Turner P, Madden F: Coping and the outcome of stoma surgery. J Psychosom Res 32:457-467, 1988.
147. Viitamaki RO: Psychological determinants of cancer. Cancer and Psyche. Monogr Psychiatr Clin Helsinki 1:45-142, 1970.
148. Weisman A, Worden J: Psychological analysis of cancer deaths. Omega: J Death Dying 6:61-75, 1975.
149. Kissane DW: Managing anger in palliative care. Austral Fam Physician 23:1257-1259, 1994.
150. Kuebler-Ross E: On Death and Dying. New York, Macmillan, 1969.
151. Blanco-Gonzales AL, Ledesma-Jimeno A, Llorca-Ramon G, et al: Aspectos psicopatologicos de las neoplasias hematologicas (Psychopathological aspects of hematological neoplasms). Acta Luso Espagnol Neurol Psiquiatr Cienc Afines 16:375-384, 1988.
152. Davies HH, Quinlan DM, McKegrey FP, et al: Organic factors and psychological adjustment in advanced cancer patients. Psychosom Med 35:464-471, 1973.
153. Derogatis LR, Abeloff MD, Melisaratos N: Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 242:1504, 1979.
154. Holland JC, Korzun AH, Tross S, et al: Psychosocial factors and disease free survival (DFS) in stage II breast carcinoma. Proc ASCO 5:237, 1986 (abstract).
155. Levy SM, Wise BD: Psychosocial risk factors in cancer prognosis. In: Stress and Breast Cancer, edited by CR Cooper, London, Wiley, 1988, pp. 77-97.
156. Rogentine GN, van Kammen DP, Fox BH, et al: Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom Med 41:647-655, 1979.
157. Spiegel D, Bloom JR, Yalom ID: Group support for patients with metastatic cancer: a randomized prospective outcome study. Arch Gen Psychiatr 38:527-533, 1981.
158. Stavraky KM: Psychological factors in the outcome of human cancer. J Psychosom Res 12:251-259, 1968.
159. Bovbjerg DH, Valdimarsdortir HB: Breast cancer patients show altered relations between distress and natural cytotoxic activity. Paper presented at the Research Perspectives in Psychoneuroimmunology IV Conference, Boulder, CO.
160. Fawzy FI, Kemeny ME, Fawzy NW, et al: A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatr 47:729-735, 1990.
161. Ironson G, Friedman A, Klimas N, et al: Distress, denial, and low adherence to behavioral interventions predict faster disease progression in HIV-1 infected gay men. Intern I Behav Med 1: 90-105, 1994.
162. Jamner LD, Schwartz GE, Leigh H: The relationship between repressive and defensive coping styles and monocyte, eosinophile and serum glucose levels: support for the opioid-peptide hypothesis of repression. Psychosom Med 50:567-575, 1988.
163. Anderson JA, Hall NRS, Spielberger CD, et al: The effect of a repressive coping style on the immune system. Paper presented at Proceedings of the Twenty Third Congress of the International Society of Psychoneuroendoctrinology, Madison, WI.
164. Shea JD, Burton R, Girgis A: Negative affect, absorption, and immunity. Physiol Behav 53:449-457, 1993.
165. Esterling BA, Antoni MH, Mahendra K, et al: Emotional repression, stress disclosure responses and Epstein-Barr viral capsid antigen titers. Psychosom Med 52:397-410, 1990.
166. O'Leary A: Stress, emotion and human immune function. Psycho Bull 108:363-382, 1990.
167. Pennebaker JW, Kiecolt-Glaser JK, Glaser R: Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 56:239-245, 1988.
168. Esterling BA, Antoni MH, Fletcher MA: Emotional disclosure through writing or speaking modulates latent Epstein-Barr virus reactivation. J Consul Clin Psychol 56:239-245, 1993.
169. Pennebaker JW: Inhibition as the linchpin. In: Hostility, Coping and Health, edited by HS Friedman. Washington, DC, American Psychological Association, 1992.
170. Laudenslager ML, Ryan SM, Drugan RC, et al: Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221:568-570, 1983.
171. Millar DB, Thomas JR, Pacheco ND, et al: Natural killer cell cytotoxicity and T-cell proliferation is enhanced by avoidance behavior. Brain Behav Immun 7:144-153, 1993.
172. Shavit Y, Lewis J, Terman G, et al: Opiod peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223:188-190, 1984.
173. Sklar LS, Anisman H: Social stress influences tumor growth. Psychosom Med 42:347-365, 1980.
174. Wegner DM, Short JW, Blake AW, et al: The suppresion of exciting thoughts. J Personality Soc Psychol 58:409-418, 1990.
175. Mesters I, van den Borne H, McCormick L, et al: Openness to discuss cancer in the nuclear family: scale, development, and validation. Psychosom Med 59:269-279, 1997.
176. Erbil P, Razavi D, Farvacques C, et al: Cancer patients psychological adjustment and perception of illness: cultural differences between Belgium and Turkey. Support Care Cancer 4:455-461, 1996.
177. Kreitler S, Kreitler H: The cognitive determinants of defense mechanisms. In: The Concept of Defense Mechanisms in Contemporary Psychology, edited by U Hentschel, GJW Smith, W Ehlers, et al, New York, Springer-Verlag, 1993, pp. 152-183.
178. Kreitler S, Kreitler H: Cognitive orientation and physical disease or health. Eur J Personality 5:109-129, 1991.